{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:47:48Z","timestamp":1787021268306,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1208\/s12249-010-9389-9","type":"journal-article","created":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T19:12:22Z","timestamp":1267470742000},"page":"336-343","source":"Crossref","is-referenced-by-count":28,"title":["Development and Characterization of Enteric-Coated Immediate-Release Pellets of Aceclofenac by Extrusion\/Spheronization Technique Using \u03ba-Carrageenan as a Pelletizing Agent"],"prefix":"10.1208","volume":"11","author":[{"given":"Vaishali A.","family":"Kilor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi P.","family":"Sapkal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine G.","family":"Awari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharti D.","family":"Shewale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,3]]},"reference":[{"key":"9389_CR1","first-page":"2","volume-title":"Martindale: The complete drug reference","author":"K Parfitt","year":"1999","unstructured":"Parfitt K. Analgesic anti inflammatory and antipyretic. In: Reynolds JEF, editor. Martindale: The complete drug reference. 32nd ed. Taunton: Pharmaceutical Press; 1999. p. 2\u201312.","edition":"32"},{"key":"9389_CR2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0014-2999(97)89179-0","volume":"329","author":"R Yamazaki","year":"1997","unstructured":"Yamazaki R, Kawai S, Mastsuzaki T, Kaneda N, Hashimoto S, Yokokura T, et al. Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors. Eur J Pharmacol. 1997;329:181\u201387.","journal-title":"Eur J Pharmacol"},{"key":"9389_CR3","unstructured":"Franz M. Stabilized pharmaceutical compositions comprising an extended release nonsteroidal anti-inflammatory agent and immediate release prostaglandin. US Patent 7303761, December 4, 2007."},{"key":"9389_CR4","first-page":"22","volume":"7220434","author":"S Desai","year":"2007","unstructured":"Desai S, Nadkarni SR, Wald RJ, Debrincat GA. Dual release compositions of a cyclooxygenase-2 inhibitor. US Patent 7220434, May 22, 2007.","journal-title":"US Patent"},{"key":"9389_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijpharm.2005.06.008","volume":"302","author":"CS Yong","year":"2005","unstructured":"Yong CS, Oh YK, Lee KH, Park SM, Park YJ, Gil YS. Trials of clear aceclofenac-loaded soft capsules with accelerated oral absorption in human subjects. Int J Pharm. 2005;302:78\u201383.","journal-title":"Int J Pharm"},{"issue":"8","key":"9389_CR6","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1080\/01932690600859374","volume":"27","author":"VY Joshi","year":"2006","unstructured":"Joshi VY, Sawant MR. Study on dissolution rate enhancement of poorly water soluble drug: contributions of solubility enhancement and relatively low micelle diffusivity. J Disp Sci Technol. 2006;27(8):1141\u201350.","journal-title":"J Disp Sci Technol"},{"issue":"6","key":"9389_CR7","first-page":"378","volume":"60","author":"S Dahiya","year":"2006","unstructured":"Dahiya S, Pathak K. Physicochemical characterization and dissolution enhancement of aceclofenac-hydroxypropyl beta-cyclodextrin binary systems. PDA J Pharm Sci Technol. 2006;60(6):378\u201388.","journal-title":"PDA J Pharm Sci Technol"},{"issue":"3","key":"9389_CR8","first-page":"218","volume":"20","author":"S Muatlik","year":"2007","unstructured":"Muatlik S, Usha AN, Reddy MS, Ranjith AK, Pandey S. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies. Pak J Pharm Sci. 2007;20(3):218\u201326.","journal-title":"Pak J Pharm Sci"},{"issue":"1\u20132","key":"9389_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ijpharm.2007.09.006","volume":"350","author":"S Mutalik","year":"2008","unstructured":"Mutalik S, Anju P, Manoj K, Usha AN. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach. Int J Pharm. 2008;350(1\u20132):279\u201390.","journal-title":"Int J Pharm"},{"issue":"1&2","key":"9389_CR10","first-page":"10","volume":"1","author":"F Yesmin","year":"2008","unstructured":"Yesmin F, Talukder MMU, Islam MS, Laila S, Haque T. Evaluation of aceclofenac loaded agarose beads prepared by ionotropic gelation method. S J Pharm Sci. 2008;1(1&2):10\u20137.","journal-title":"S J Pharm Sci"},{"key":"9389_CR11","unstructured":"Margret Chandira R, Venkataeswarlu BS, Kumudhavalli MV, Bhowmik D, Jayakar B. Formulation and evaluation of the fast dissolving tablets of aceclofenac. The Pharma Review. 2008; 164\u201367."},{"issue":"2","key":"9389_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/0250-474X.41452","volume":"70","author":"C Mallikarjuna Setty","year":"2008","unstructured":"Mallikarjuna Setty C, Prasad DVK, Gupta VRM, SA B. Development of fast dispersible aceclofenac tablets: effect of functionality of superdisintegrants. Ind Pharm Sci. 2008;70(2):180\u20135.","journal-title":"Ind Pharm Sci"},{"key":"9389_CR13","first-page":"1","volume-title":"Pharmaceutical pelletization technology","author":"I Ghebre-Sellassie","year":"1989","unstructured":"Ghebre-Sellassie I. Pellets: a general overview. In: Ghebre-Sellassie I, editor. Pharmaceutical pelletization technology. New York: Marcel Dekker; 1989. p. 1\u201313. Vol.37."},{"key":"9389_CR14","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jpba.2006.02.055","volume":"41","author":"PR Nassab","year":"2006","unstructured":"Nassab PR, Rajk\u00f3 R, Szab\u00f3-R\u00e9v\u00e9sz P. Physicochemical characterization of meloxicam\u2013mannitol binary systems. J Pharm Biomed Anal. 2006;41:1191\u201397.","journal-title":"J Pharm Biomed Anal"},{"key":"9389_CR15","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3109\/03639048509057702","volume":"11","author":"RE O\u2019Connor","year":"1985","unstructured":"O\u2019Connor RE, Schwartz JB. Spheronization II: drug release from drug-diluent mixtures. Drug Dev Ind Pharm. 1985;11:1837\u201357.","journal-title":"Drug Dev Ind Pharm"},{"key":"9389_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejpb.2005.10.002","volume":"63","author":"M Thommes","year":"2006","unstructured":"Thommes M, Kleinebudde P. Use of \u03ba-carrageenan as alternative pelletization aid to microcrystalline cellulose in extrusion\/spheronization, I: influence of type and fraction of filler. Eur J Pharm Biopharm. 2006;63:59\u201367.","journal-title":"Eur J Pharm Biopharm"},{"key":"9389_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejpb.2005.10.003","volume":"63","author":"M Thommes","year":"2006","unstructured":"Thommes M, Kleinebudde P. Use of \u03ba-carrageenan as alternative pelletization aid to microcrystalline cellulose in extrusion\/spheronization, II: influence of drug and filler type. Eur J Pharm Biopharm. 2006;63:68\u201375.","journal-title":"Eur J Pharm Biopharm"},{"key":"9389_CR18","volume-title":"The United States Pharmacopeia 2004 (USP 27)","author":"USP","year":"2003","unstructured":"USP. The United States Pharmacopeia 2004 (USP 27). Toronto: Webcom Limited; 2003."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-010-9389-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-010-9389-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-010-9389-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-010-9389-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T23:48:09Z","timestamp":1559605689000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-010-9389-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["9389"],"URL":"https:\/\/doi.org\/10.1208\/s12249-010-9389-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}